EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Prism Medico & Pharmacy EBITDA Margin % Related Terms
Prism Medico & Pharmacy EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:512217 vs ADM, BG, TSN: EBITDA Margin % Comparison
For the Farm Products subindustry, Prism Medico & Pharmacy's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prism Medico & Pharmacy EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Prism Medico & Pharmacy's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Prism Medico & Pharmacy's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prism Medico & Pharmacy (BOM:512217) has a EBITDA Margin % of -43.35% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Prism Medico & Pharmacy and its competitors. According to the industry distribution chart, Prism Medico & Pharmacy ranks #400 out of 1948 companies in the Consumer Packaged Goods industry, placing it in the top 20.5%.
Is Prism Medico & Pharmacy's EBITDA Margin % too high?
Prism Medico & Pharmacy's current EBITDA Margin % is -43.35%. Based on the distribution chart, Prism Medico & Pharmacy ranks #400 out of 1948 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Prism Medico & Pharmacy has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's EBITDA Margin % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Prism Medico & Pharmacy ranks #400 out of 1948 companies for EBITDA Margin %. This places Prism Medico & Pharmacy in the top 21% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.00, based on 1,948 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Prism Medico & Pharmacy and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current EBITDA Margin % is -43.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.29, compared to a current price of ₹28.45 — trading 4.3% above its estimated fair value. The current EBITDA Margin % is -43.35%. Prism Medico & Pharmacy's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current EBITDA Margin % is -43.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?
Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued.
The current stock price of ₹28.45 is trading 4.3% above its estimated GF Value™ of ₹27.29.
GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.
Key valuation signals for BOM:512217:
EBITDA Margin %: -43.35%
GF Value™: ₹27.29 vs. price of ₹28.45 (4.3% above fair value)
No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
53GF Score
Get the complete analysis for BOM:512217
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512217 has been successfully added to your 
